Navigation Links
Growth Opportunities for Actemra Will Propel Roche to Sixth Position in the Rheumatoid Arthritis Market by 2012
Date:1/14/2009

Recent Entrants Invest Heavily in Promotion to Capture Share in Mature Market, According to a New Report from Decision Resources

WALTHAM, Mass., Jan. 14 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that growth opportunities for Roche/Chugai's Actemra (marketed as RoActemra in Europe) will propel Roche to sixth position in the rheumatoid arthritis market by 2012. Driving factors include Actemra's early market entry into Japan, making it the only agent available for the treatment of inadequate responders to TNF-alpha in Japan until the arrival of Bristol-Myers Squibb's Orencia in 2012, and the likelihood that the drug will be used in relatively early lines of biologic therapy.

Currently, physicians rely heavily on TNF-alpha inhibitors in early lines of biological therapy, and reserve agents with other mechanisms of action, such as Orencia and Biogen Idec/Genentech's Rituxan (also marketed by Chugai and Zenyaku Kogyo in Japan, and marketed as MabThera in Europe by Roche), largely for TNF-alpha inadequate responders. According to the new report entitled Brands & Strategies: Rheumatoid Arthritis, physicians indicate that Actemra's efficacy data is compelling enough to consider using it earlier in therapy; particularly once it has been on the market long enough to gather some post-marketing data to provide reassurance about side effects such as elevated lipid levels and elevated liver enzymes.

"Despite a recent regulatory setback in the U.S., physicians are cautiously optimistic about the efficacy of Actemra," said Dancella Fernandes, Ph.D., analyst at Decision Resources. "Decision Resources anticipates the drug's uptake as a treatment for inadequate responders to TNF-alpha will garner Actemra sales of $603 million in 2012."

The report also finds despite significant increases in promotional spend coinciding with the launch of Orencia and Rituxan, these relatively new entrants are struggling to secure significant market share in the mature rheumatoid arthritis market. Promotional spending doubled and increased tenfold (for Orencia and Rituxan, respectively) in 2006 compared with 2005. While Rituxan's spend remained similar in 2007 compared to 2006, Orencia's spend increased fivefold in 2007. Despite these efforts, only one percent of surveyed rheumatologists reported that Orencia or Rituxan was the first brand that came to mind when thinking of rheumatoid arthritis treatments.

About Brands & Strategies

The Brands & Strategies report series from Decision Resources reveals what it takes to be successful in a pharmaceutical market. It offers the most comprehensive commercial analysis of the brands and strategies of competing companies, insight from physicians and patients, and forecasted impact of future events. Brands & Strategies is the first and only report series to bring together all the competitive information elements pharma companies need to better position themselves in a market and plan future strategy based on what competitors are doing.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in healthcare market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Heather Hilty                   Elizabeth Marshall
    Decision Resources              Decision Resources, Inc.
    781-296-2536                    781-296-2563
    hhilty@dresources.com           emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Economic Uncertainty Fuels Vendormate Growth in 2008
2. Access Family Services, Inc. Makes the List for the Second Year in a Row! Access Family Services 2008 Ranks No. 2851 on the Inc. 5000 With Three-Year Sales Growth of 128%
3. Growth in the Functional Food Sector Gives a Hearty Boost to the Heart Health Ingredients Market
4. Hanger Orthopedic Group Welcomes Vinit Asar as Chief Growth Officer
5. Varian Medical Systems Announces Net Orders Growth Estimates for the First Quarter of Fiscal Year 2009
6. Abaxis, Inc. to Present at Sidoti & Companys Sixth Annual Palm Beach Emerging Growth Institutional Investor Forum
7. TeleTracking Technologies to Focus on Growth
8. Cantel Medical Corp. to Present at the 11th Annual Needham Growth Stock Conference
9. Physician Staffing Trends and Hospitalist Jobs Fuel Growth at Locum Leaders
10. Abaxis, Inc. to Present at Needham & Companys Eleventh Annual Growth Stock Conference
11. Fisher Vista, LLC Reports Seventh Consecutive Year of Revenue Growth and Profitability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... 12, 2017 , ... Planet Fitness, one of the largest and fastest growing ... open a flagship location in Covington, LA at 401 N. U.S. Highway 190, in ... to Office Depot in the Holiday Square shopping center. Its location allows it to ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... 2017  True Health, a leader in integrated ... during National Breast Cancer Awareness month to educate ... Research recently published ... more than 10 million American women are at ... or BRCA2 and have not had testing. These mutations ...
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/7/2017)... 2017   Provista, a proven leader in ... in purchasing power, today announced a new resource area ... Newsroom is the online home for case studies, ... bios, news releases, slideshows and events. ... of resources at their fingertips, viewers can also watch ...
Breaking Medicine Technology: